Protagonist Therapeutics Inc (PTGX)
Stock-Based Compensation
$49.82M
TTM · Period ending: · USD
PTGX Stock-Based Compensation
Latest reported$49.82Mperiod ending
Latest reported$49.82Mperiod ending
PTGX TTM Stock-Based Comp ($99.00K → $49.82M)
TTM stock-based compensation
High-resolution chart · PNG
PTGX stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 49,816,000 | |
| 46,691,000 | |
| 45,974,000 | |
| 44,366,000 | |
| 43,972,000 | |
| 42,004,000 | |
| 37,554,000 | |
| 35,062,000 | |
| 31,662,000 | |
| 31,061,000 | |
| 29,293,000 | |
| 28,204,000 | |
| 27,389,000 | |
| 25,851,000 | |
| 24,202,000 | |
| 23,714,000 | |
| 22,539,000 | |
| 19,670,000 | |
| 16,395,000 | |
| 13,338,000 | |
| 10,451,000 | |
| 8,511,000 | |
| 7,899,000 | |
| 5,932,000 | |
| 6,245,000 | |
| 6,262,000 | |
| 6,193,000 | |
| 8,265,000 | |
| 8,081,000 | |
| 7,713,000 | |
| 6,919,000 | |
| 6,036,000 | |
| 5,226,000 | |
| 4,583,000 | |
| 4,241,000 | |
| 4,572,000 | |
| 3,813,000 | |
| 2,917,000 | |
| 2,130,000 | |
| 647,000 | |
| 221,000 | |
| 136,000 | |
| 99,000 |